Gardner Lewis Asset Management’s Surmodics SRDX Stock Holding History

Gardner Lewis Asset Management’s Portfolio SRDX Stock Details SRDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-46,979	Closed	-$1.4M	–	99
2025 Q3	$1.4M	Hold	46,979	–	–	0.33%	52
2025 Q2	$1.4M	Sell	46,979 -14,678	-24%	-$423K	0.35%	58
2025 Q1	$1.88M	Sell	61,657 -201,221	-77%	-$6.77M	0.45%	52
2024 Q4	$10.4M	Buy	262,878 +49,944	+23%	+$1.94M	2.52%	16
2024 Q3	$8.26M	Buy	212,934 +10,000	+5%	+$405K	2.32%	18
2024 Q2	$8.53M	Buy	+202,934	New	+$6.92M	2.34%	16

Other funds holding SRDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Gardner Lewis Asset Management's SRDX Position: Q4 2025 in Review

Gardner Lewis Asset Management sold out of Surmodics (SRDX) in Q4 2025, closing a stake of 46,979 shares — an estimated $1.4M sold.

Gardner Lewis Asset Management first reported a position in SRDX in Q2 2024 and held it in 6 quarters. The position peaked at $10.4M in Q4 2024. 1 fund tracked by Wall St. Rank holds SRDX as of Q4 2025.

Gardner Lewis Asset Management reported no remaining Surmodics position as of Q4 2025 after selling out during the quarter.
Gardner Lewis Asset Management sold 46,979 Surmodics shares in Q4 2025, an estimated $1.4M.
Gardner Lewis Asset Management first reported a position in Surmodics in Q2 2024 and held it in 6 quarters.
Gardner Lewis Asset Management's Surmodics position peaked at $10.4M in Q4 2024.
1 fund tracked by Wall St. Rank held Surmodics as of Q4 2025.

Based on Gardner Lewis Asset Management's 13F filing for Q4 2025, filed 12 Feb 2026.